Myriad Genetics, Inc.’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $24.21 on 06/30/23 and a low of $13.82 for the same time frame on 10/30/23.
52-week price history of MYGN Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Myriad Genetics, Inc.’s current trading price is -18.22% away from its 52-week high, while its distance from the 52-week low is 43.27%. The stock’s price range during this period has spanned from $13.82 to $24.21. In the Healthcare sector, the Myriad Genetics, Inc.’s shares surpassed a trading volume of approximately 1.31 million for the day, which was noticeably higher compared to the average daily volume of 9.0.61 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Myriad Genetics, Inc. (MYGN) has experienced a quarterly decline of -12.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.78B and boasts a workforce of 2700 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 20.76, with a change in price of +1.19. Similarly, Myriad Genetics, Inc. recorded 652,016 in trading volume during the last 100 days, posting a change of +6.39%.
Examining MYGN’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for MYGN stands at 0.19. Similarly, the long-term debt-to-equity ratio is also 0.17.
MYGN Stock Stochastic Average
Today, Myriad Genetics, Inc.’s raw stochastic average for the past 50 days stands at 32.48%, indicating a decline from the raw stochastic average of the last 20 days, which was 59.94%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 23.12% and 12.60% respectively.
MYGN Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 3.45%. However, over the last six months, the performance has been weaker by 39.34%. The price of MYGN decreased -7.13% over the last 30 days. And in the last five days, it has surged by 7.08%.
